NCI Requests Targets for Monoclonal Antibody Production and CharacterizationThe Antibody Characterization Program in NCI's Office of Cancer Clinical Proteomics Research provides researchers with reagents and other critical resources that support protein/peptide measurements and analysis. In an effort to provide well-characterized monoclonal antibodies to the scientific community, the program requests cancer-related protein targets for affinity production and distribution. Submissions will be accepted through July 9.
Submissions will be reviewed and considered for merit based on their justification and contribution to existing NCI-funded projects. Priority will be given to projects that apply the antibodies to proteomics research.
Successful applicants can expect to be notified on or before August 30. All materials (such as proteins/peptides) must be ready and available when a target is submitted. For more information and the application form, please go to NCI's Antibodies Data Portal.
Please address questions to Dr. Tara Hiltke at email@example.com or 301-451-8511.